- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07661355
Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
For all patients, the transition from hospital to home is a vulnerable period, placing them at great risk for adverse events. In a landmark 2003 report on care transitions, investigators found that 19% of patients experience adverse events soon after discharge (many preventable or ameliorable) and 66% experience adverse drug events. Care transitions also impact those around the recently discharged patient - increasing the burden on family members who provide caregiving support. Without communication and engagement in care transitions, family members experience reduced preparedness for their post-discharge caregiving role, increased caregiver burden, social isolation, and reduced mental/physical well-being.
Patient-centered care transitions can be supported through evidence-based interventions. Recent knowledge generated through PCORI's Transitional Care Evidence to Action Network and other research programs has identified remaining evidence gaps. This Phased Large Award for Comparative Effectiveness Research entitled Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers will create new knowledge related to engaging and supporting family caregivers. After optimization in the feasibility phase, briefly, the Phase 2 comparative effectiveness trial will have the following characteristics:
Setting: 20 Acute Care Hospitals across 5 states selected for rural/urban diversity and patient characteristics Sample: Dyads: Older Adults (N = 1,200) discharged to home and their Family Caregivers (N = 1,200)
Comparators:
Comparator A is an active care transition intervention that includes effective strategies focused on the patient.
Comparator B includes all Comparator A active strategies, plus focused family caregiver engagement and support.
Randomization:
1:1 Dyad-level RCT stratified by rural/urban home setting and presence of patient cognitive impairment
Patient-Centered Outcomes Include: Patient remaining safely at home (60-day hospital free days), post-discharge adverse events, patient-reported outcomes (e.g.: role functioning). Also, this study extends beyond prior effectiveness research by assessing family-caregiver-reported outcomes (e.g.: caregiver burden).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michiyah Kimber
- Phone Number: 336-716-2236
- Email: michiyah.kimber@advocatehealth.org
Study Contact Backup
- Name: Erica Hale
- Phone Number: 3367162236
- Email: erica.hale@advocatehealth.org
Study Locations
-
-
North Carolina
-
Bermuda Run, North Carolina, United States, 27006
- Davie Medical Center
-
Contact:
- Houston
- Phone Number: 508-688-4341
- Email: Thomas.Houston@advocatehealth.org
-
High Point, North Carolina, United States, 27262
- High Point Medical Center
-
Contact:
- Houston
- Phone Number: 508-688-4341
- Email: Thomas.Houston@advocatehealth.org
-
North Wilkesboro, North Carolina, United States, 28659
- Atrium Health Wake Forest Baptist Wilkes Medical Center
-
Contact:
- Houston
- Phone Number: 508-688-4341
- Email: Thomas.Houston@advocatehealth.org
-
Winston-Salem, North Carolina, United States, 27157
- Atrium Health Wake Forest Baptist Medical Center
-
Contact:
- Houston
- Phone Number: 508-688-4341
- Email: Thomas.Houston@advocatehealth.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Patient Inclusion Criteria:
- 65 and older
- English and Spanish speaking
- Preadmission location: community dwelling
- Distance from Hospital: Local and Distant (rural) included
- Cognitive impairment, dementia allowed
- Technology Literacy: Flexible from high to low
- EPIC readmission risk score over 12
- Discharged home
Patient Exclusion Criteria:
- Admitted from skilled nursing facility
- Discharged to skilled nursing facility
- Left Against Medical Advice (AMA)
- Planned readmission
- Died during index admission
- Caregiver unwilling to participate
Caregiver Inclusion Criteria:
- Adults 18 and older
- English and Spanish speaking
- Providing tangible support to patient
- Distance from Hospital: Local and Distant (rural) included
- Only Mild Cognitive Impairment allowed
- Able to be trained in Video Visit Technology
- Available to support post-discharge
Caregiver Exclusion Criteria:
• Has a greater than a mild cognitive impairment (≤ 22 on MCA)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Patient Focused Strategies
An active care transition intervention that includes effective strategies focused on the patient.
|
Effective strategies focused on the patient such as patient needs assessment, multi-disciplinary discharge planning, discharge instructions, follow-up education, and follow-up assessments.
|
|
Experimental: Patient and Family Focused Strategies
An active care transition intervention that includes effective strategies focused on the patient plus focused family caregiver engagement and support.
|
Effective strategies focused on the patient such as patient needs assessment, multi-disciplinary discharge planning, discharge instructions, follow-up education, and follow-up assessments.
Caregiver strategies such as a family caregiver needs assessment, structured education, and skill building.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital-Free Days
Time Frame: Day 60
|
The count of days alive and outside acute care hospitals from discharge to day 60.
It will be calculated using EHR and Medicare claims data to objectively capture hospital free days elements (i.e.: mortality days, inpatient days, observation stays, and ED visits).
|
Day 60
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Hospital-Free Days
Time Frame: Day 30, 90, and 180
|
The count of days alive and outside acute care hospitals from discharge to a specified day.
It will be calculated using EHR and Medicare claims data to objectively capture hospital free days elements (i.e.: mortality days, inpatient days, observation stays, and ED visits).
|
Day 30, 90, and 180
|
|
Number of Patient Readmissions
Time Frame: Day 30, 60, and 90
|
All-cause, acute care readmissions calculated as both a count and dichotomous using EHR and Medicare claims data.
|
Day 30, 60, and 90
|
|
Zarit Burden Interview Score
Time Frame: Day 60
|
Caregiver burden will be measured using the 12-item Zarit Burden Interview.
Scores will range from 0 to 48.
Higher scores indicate greater burden.
|
Day 60
|
|
Zarit Burden Interview Score
Time Frame: Day 30, 90, and 180
|
Caregiver burden will be measured using the 12-item Zarit Burden Interview.
Scores will range from 0 to 48.
Higher scores indicate greater burden.
|
Day 30, 90, and 180
|
|
PROMIS Ability to Participate in Social Roles and Activities 8-item short form (APS-SF8) Score
Time Frame: Day 60
|
Social role function is one's ability to perform usual social roles and activities (e.g.: leisure, family).
It will be measured by using the APS-SF8.
Each item is scored using a 5-point Likert scale (1=Never, 5=Always).
Scores are typically converted to a standardized T-score, with a mean of 50 and a standard deviation of 10.
|
Day 60
|
|
PROMIS Ability to Participate in Social Roles and Activities 8-item short form (APS-SF8) Score
Time Frame: Day 30, 90 and 180
|
Social role function is one's ability to perform usual social roles and activities (e.g.: leisure, family).
It will be measured by using the APS-SF8.
Each item is scored using a 5-point Likert scale (1=Never, 5=Always).
Scores are typically converted to a standardized T-score, with a mean of 50 and a standard deviation of 10.
|
Day 30, 90 and 180
|
|
Partners at Care Transitions Measure (PACT-M) - Patient Satisfaction Score
Time Frame: Day 7
|
Patient satisfaction will be measured using the 9-item PACT-M-1.
Scores will range from 9 to 45. Higher scores indicate better perception of the quality of discharge arrangements.
|
Day 7
|
|
Partners at Care Transitions Measure (PACT-M) - Patient Self-Efficacy Score
Time Frame: Day 30
|
Patient self-efficacy will be measured using the 8-item PACT-M-2.
Scores will range from 8 to 40.
Higher scores indicate a better experience with managing care at home.
|
Day 30
|
|
Patient Activation Measures Score
Time Frame: Day 60
|
Patient activation will be measured using the 13-item Patient Activation Measures.
Scores will range from 0 to 100.
Higher scores indicate greater knowledge, skills, and confidence for managing their health and health care.
|
Day 60
|
|
Preparedness for Caregiving Scale Score
Time Frame: Day 7
|
Family caregiver preparedness will be measured using the 8-item Preparedness for Caregiving Scale.
Scores will range from 0 to 32.
Higher scores indicate better preparedness for the caregiving role.
|
Day 7
|
|
Caregiver Self-Efficacy Scale Score
Time Frame: Day 30
|
Family caregiver self-efficacy will be measured using the 8-item Caregiver Self-Efficacy Scale.
Scores will range from 8 to 80. Higher scores indicate higher self-efficacy.
|
Day 30
|
|
Caregiver Activation Measures Score
Time Frame: Day 60
|
Patient activation will be measured using the 13-item Caregiver Activation Measures.
Scores will range from 0 to 100.
Higher scores indicate greater knowledge, skills, and confidence for managing their health and health care.
|
Day 60
|
|
Visit Completion Rate
Time Frame: Day 14 and 30
|
Number of patients that completed follow-up visit
|
Day 14 and 30
|
|
Time to First Outpatient Follow-up
Time Frame: Day 14 and 30
|
Number of days between discharge and first outpatient follow-up visit
|
Day 14 and 30
|
|
Rate of Access to Community Services - Patient
Time Frame: Day 30 and 60
|
Number of patients that had screening and intervention assessment for unmet social needs.
|
Day 30 and 60
|
|
Rate of Access to Community Services - Caregiver
Time Frame: Day 30 and 60
|
Number of caregivers that had screening and intervention assessment for unmet social needs
|
Day 30 and 60
|
|
Partners at Care Transitions Measures - Adverse Events Score
Time Frame: Day 7 and 30
|
Adverse events will be measured using the 7-item Partners at Care Transitions Measures.
Scores will range from 7 to 30.
Higher scores indicate greater care problems and more adverse events post discharge.
|
Day 7 and 30
|
|
Mortality Rate
Time Frame: Day 60 and 180
|
Count of days to date of patient death
|
Day 60 and 180
|
|
Montreal Cognitive Assessment 5-minute Protocol Score
Time Frame: Day 0, 60, and 180
|
Cognitive function (attention, orientation, language, memory, and executive function) will be measured using the Montreal Cognitive Assessment 5-min protocol.
Scores will range from 0 to 30.
Higher scores indicate better cognitive function.
|
Day 0, 60, and 180
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Thomas Houston, MD, Wake Forest University Health Sciences
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00145199
- PLACER-2025C1-43844 (Other Grant/Funding Number: Patient Centered Outcomes Research Institute)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Care Transition
-
Lisa TuchmanHealth Resources and Services Administration (HRSA)CompletedCare Coordination | Health Care Transition
-
University of WashingtonDonaghue Medical Research FoundationCompletedTransition of CareUnited States
-
University of RochesterAcademic Pediatric AssociationCompletedTransition to Adult Health CareUnited States
-
University of WashingtonAgency for Healthcare Research and Quality (AHRQ)CompletedCare TransitionUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
StratiHealthNot yet recruitingCare Transitions | Complex Care | Population Health Management | Housing Instability | Post-Acute Care Utilization | Residential Care TransitionUnited States
-
Daniel Forman, MDWashington University School of Medicine; University of Pittsburgh; National...CompletedCardiovascular Diseases | Cardiac Rehabilitation | Transition of CareUnited States
-
Massachusetts General HospitalRecruitingColorectal Surgery | Care Transition | Older Adults (65 Years and Older)United States
-
Trillium Health PartnersCentre for Aging and Brain Health InnovationUnknownCommunication | Care TransitionCanada
-
Holbaek SygehusRegion Sjælland; Danish Institute for Public HealthCompletedFrailty | Readmission | Primary Care | TransitionDenmark
Clinical Trials on Patient-Centered Intervention
-
University of PennsylvaniaCompletedGeneral Medical Inpatient ConditionsUnited States
-
Sint MaartenskliniekRadboud University Medical CenterCompletedMusculoskeletal Diseases | Rheumatoid ArthritisNetherlands
-
Agency for Healthcare Research and Quality (AHRQ)National Institute of Mental Health (NIMH); Aetna, Inc.Unknown
-
Vanderbilt University Medical CenterNational Institute on Aging (NIA)CompletedPolypharmacy | Geriatric Syndromes | Care TransitionsUnited States
-
Shifa Tameer-e-Millat UniversityCompleted
-
Göteborg UniversityVastra Gotaland RegionCompletedGingivitis | Periodontal InfectionSweden
-
Beth Israel Deaconess Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedChronic Kidney Disease | End-Stage Renal DiseaseUnited States
-
Mukoviszidose Institut gGmbHHannover Medical School; Goethe University; Federal Ministry of Health, Germany; Wuerzburg University Hospital and other collaboratorsCompleted
-
Abramson Cancer Center at Penn MedicineEnrolling by invitation
-
Universitair Ziekenhuis BrusselHasselt University; Ziekenhuis Oost-Limburg; Vrije Universiteit Brussel; Kom Op...RecruitingBreast Cancer | Breast Neoplasms | SurgeryBelgium